CHMP2A as a potential prognostic biomarker for esophageal squamous cell carcinoma promotes tumor angiogenesis and cancer progression

doi:10.4251/wjgo.121843

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

(4)

(10)

(0)

(16)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121843
Published online Oct 15, 2026. doi: 10.4251/wjgo.121843

Full Size Figure Download Figure

Figure 1 CHMP2A expression is significantly upregulated in multiple tumor types and correlates with the level of immune cell infiltration. A: CHMP2A mRNA levels across different cancer types from The Cancer Genome Atlas data; B and C: Correlation analysis of CHMP2A mRNA with overall survival and progression-free interval in tumor patients; D: Correlation between CHMP2A expression levels and the degree of immune cell infiltration. The numbers in the heatmap represent the corresponding P values of the correlation analysis. ^aP < 0.05; ^bP <0.01. TPM: Transcripts per million; ESCA: Esophageal carcinoma.

Citation: Ma LL, Hao MF, Chen MX, Lu YJ, Su JT, Tong S, Wang JW, Li X, Wei LY, Wang WW, Duan XX, Wang JS. CHMP2A as a potential prognostic biomarker for esophageal squamous cell carcinoma promotes tumor angiogenesis and cancer progression. World J Gastrointest Oncol 2026; 18(10): 121843
URL: https://www.wjgnet.com/1948-5204/full/v18/i10/121843.htm
DOI: https://dx.doi.org/10.4251/wjgo.121843

Ma LL, Hao MF, Chen MX, Lu YJ, Su JT, Tong S, Wang JW, Li X, Wei LY, Wang WW, Duan XX, Wang JS. CHMP2A as a potential prognostic biomarker for esophageal squamous cell carcinoma promotes tumor angiogenesis and cancer progression. World J Gastrointest Oncol 2026; 18(10): 121843 [DOI: 10.4251/wjgo.121843]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.